Vimarsana
Biggest News Aggregation in the World

Associate Bioengineer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Associate Bioengineer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Associate Bioengineer Today - Breaking & Trending Today

Akita Biosciences Launches to Pioneer Novel Intranasal Therapies - Vimarsana News

Akita Biosciences Launches to Pioneer Novel Intranasal Therapies

/PRNewswire/ -- Akita Biosciences, a biotechnology company focused on consumer health, is launching today with a mission to bring novel therapies to market....

New technique combines bioprinting with cryopreservation to construct frozen structures - Vimarsana News

New technique combines bioprinting with cryopreservation to construct frozen structures

A new technique takes bioprinting -; in which an ink of cells is printed, layer by layer, to form a structure -; to a whole new, and icy level. Investigators from the Zhang lab at Brigham and Women's Hospital have developed a technology that they term "cryobioprinting," a method that uses a bioink embedded with cells to print frozen, complex structures that can be easily stored for later use.

3D 'lung-on-a-chip' model to test new therapies for Covid - Vimarsana News

3D 'lung-on-a-chip' model to test new therapies for Covid

A team of researchers has designed a 3D "lung-on-a-chip" model that replicates human alveolar lung tissue to test new therapies for Covid-19 and other lung conditions.The model will help study how Covid viral particles travel through ...

New Nanoparticle Platform Could Help Treat Various Neurological Disorders - Vimarsana News

New Nanoparticle Platform Could Help Treat Various Neurological Disorders

New Nanoparticle Platform Could Help Treat Various Neurological Disorders Written by AZoNanoJan 4 2021 Over the last few decades, scientists have established the biological pathways that cause neurodegenerative diseases and have created potential molecular agents to target these pathways. Yet, there has been a delay in translating these discoveries into clinically approved treatments, partially due to the challenges faced by researchers in delivering therapeutics into the brain through the blood-brain barrier (BBB). To enable the successful delivery of therapeutic agents into the brain, a gro...